BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 22322424)

  • 1. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ; Aigner L; Rivera FJ; Küry P
    Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
    Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH
    Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D; Aktas O; Hartung HP; Küry P
    Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
    Rivera FJ; Aigner L
    Biol Res; 2012; 45(3):257-68. PubMed ID: 23283435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why does remyelination fail in multiple sclerosis?
    Franklin RJ
    Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration and repair in multiple sclerosis: the view of experimental pathology.
    Blakemore WF
    J Neurol Sci; 2008 Feb; 265(1-2):1-4. PubMed ID: 17459413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders.
    Pluchino S; Martino G
    J Neurol Sci; 2005 Jun; 233(1-2):117-9. PubMed ID: 15896808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirteen compounds promoting oligodendrocyte progenitor cell differentiation and remyelination for treating multiple sclerosis: WO2010054307.
    Taupin P
    Expert Opin Ther Pat; 2010 Dec; 20(12):1767-73. PubMed ID: 20954805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do central nervous system axons remyelinate?
    Nait-Oumesmar B; Lachapelle F; Decker L; Baron-Van Evercooren A
    Pathol Biol (Paris); 2000 Feb; 48(1):70-9. PubMed ID: 10729914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice.
    Cristofanilli M; Harris VK; Zigelbaum A; Goossens AM; Lu A; Rosenthal H; Sadiq SA
    Stem Cells Dev; 2011 Dec; 20(12):2065-76. PubMed ID: 21299379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular remyelinating therapy in multiple sclerosis.
    Yang J; Rostami A; Zhang GX
    J Neurol Sci; 2009 Jan; 276(1-2):1-5. PubMed ID: 18814888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remyelination in demyelinating disease.
    Scolding NJ; Franklin RJ
    Baillieres Clin Neurol; 1997 Oct; 6(3):525-48. PubMed ID: 10101588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
    Motavaf M; Sadeghizadeh M; Javan M
    Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.
    Zujovic V; Thibaud J; Bachelin C; Vidal M; Coulpier F; Charnay P; Topilko P; Baron-Van Evercooren A
    Stem Cells; 2010 Mar; 28(3):470-9. PubMed ID: 20039366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell transplantation in multiple sclerosis.
    Uccelli A; Mancardi G
    Curr Opin Neurol; 2010 Jun; 23(3):218-25. PubMed ID: 20375893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.